The White House launched two major pharmaceutical policy initiatives in May 2025: bringing drug manufacturing back to US soil and implementing price controls on prescription medications. The Manufacturing Strategy The May 5th executive order aims to cut the 5-10 year timeline currently needed to build pharmaceutical plants in the US. The FDA, EPA, and Army Corps of Engineers must streamline their facility approval processes within 180 days. Key Changes: “Importing foreign prices from socialist countries would be a bad deal for American patients and workers,” says Stephen J. Ubl, PhRMA’s president. “It would mean less treatments and cures and would … Continue reading Trump Orders Drug Price Cuts in 30 Days and Fast-Tracks US Pharma Plants Facing 5–10 Year Delays